Genetic analysis of CHCHD2 gene in Chinese Parkinson's disease

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 171, Issue 8, 2016, Pages 1148-1152

  Li, Nan Nan ^a   Wang, Ling ^a   Tan, Eng King ^b,c   Cheng, Lan ^a   Sun, Xiao Yi ^a   Lu, Zhong Jiao ^a   Li, Jun Ying ^a   Zhang, Jin Hong ^a,d   Peng, Rong ^a  

^a SICHUAN UNIVERSITY   (China)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

^d SICHUAN UNIVERSITY   (China)

Author keywords

Asian population; CHCHD2; Chinese; Parkinson's disease

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CHCHD2 GENE; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; POPULATION GENETICS; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; VERY ELDERLY; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CHINA; GENE FREQUENCY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; GENOTYPE; METABOLISM; MIDDLE AGED; MUTATION;

CHCHD2 PROTEIN, HUMAN; LEUCINE; MITOCHONDRIAL PROTEIN; PROLINE; TRANSCRIPTION FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; HUMANS; LEUCINE; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; MUTATION; PARKINSON DISEASE; PROLINE; RISK FACTORS; TRANSCRIPTION FACTORS;

EID: 84992549171     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32498     Document Type: Article

References (22)

1. Aras S, Bai M, Lee I, Springett R, Huttemann M, Grossman LI. 2015. MNRR1 (formerly CHCHD2) is a bi-organellar regulator of mitochondrial metabolism. Mitochondrion 20:43–51.
2. Baughman JM, Nilsson R, Gohil VM, Arlow DH, Gauhar Z, Mootha VK. 2009. A computational screen for regulators of oxidative phosphorylation implicates SLIRP in mitochondrial RNA homeostasis. PLoS Genet 5:e1000590.
3. De Rosa P, Marini ES, Gelmetti V, Valente EM. 2015. Candidate genes for Parkinson disease: Lessons from pathogenesis. Clin Chim Acta 449:68–76.
4. Fan TS, Lin HI, Lin CH, Wu RM. 2016. Lack of CHCHD2 mutations in Parkinson's disease in a Taiwanese population. Neurobiol Aging 38:e211–e212.
5. Foo JN, Liu J, Tan EK. 2015. CHCHD2 and Parkinson's disease. Lancet Neurol 14:681–682.
6. Funayama M, Ohe K, Amo T, Furuya N, Yamaguchi J, Saiki S, Li Y, Ogaki K, Ando M, Yoshino H, Tomiyama H, Nishioka K, Hasegawa K, Saiki H, Satake W, Mogushi K, Sasaki R, Kokubo Y, Kuzuhara S, Toda T, Mizuno Y, Uchiyama Y, Ohno K, Hattori N. 2015. CHCHD2 mutations in autosomal dominant late-onset Parkinson's disease: A genome-wide linkage and sequencing study. Lancet Neurol 14:274–282.
7. Hughes AJ, Daniel SE, Kilford L, Lees AJ. 1992. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184.
8. Iqbal Z, Toft M. 2015. CHCHD2 and Parkinson's disease. Lancet Neurol 14:680–681.
9. Jansen IE, Bras JM, Lesage S, Schulte C, Gibbs JR, Nalls MA, Brice A, Wood NW, Morris H, Hardy JA, Singleton AB, Gasser T, Heutink P, Sharma M. 2015. CHCHD2 and Parkinson's disease. Lancet Neurol 14:678–679.
10. Koschmidder E, Weissbach A, Bruggemann N, Kasten M, Klein C, Lohmann K. 2016. A nonsense mutation in CHCHD2 in a patient with Parkinson disease. Neurology 86:577–579.
11. Liu G, Li K. 2015. CHCHD2 and Parkinson's disease. Lancet Neurol 14:679–680.
12. Liu Y, Clegg HV, Leslie PL, Di J, Tollini LA, He Y, Kim TH, Jin A, Graves LM, Zheng J, Zhang Y. 2015. CHCHD2 inhibits apoptosis by interacting with Bcl-x L to regulate Bax activation. Cell Death Differ 22:1035–1046.
13. Longen S, Bien M, Bihlmaier K, Kloeppel C, Kauff F, Hammermeister M, Westermann B, Herrmann JM, Riemer J. 2009. Systematic analysis of the twin cx(9)c protein family. J Mol Biol 393:356–368.
14. Lu Q, Deng X, Song Z, Guo Y, Yang Y, Deng H. 2016. Mutation analysis of the CHCHD2 gene in Chinese Han patients with Parkinson's disease. Parkinsonism Relat Disord 29:143–144.
15. Ogaki K, Koga S, Heckman MG, Fiesel FC, Ando M, Labbe C, Lorenzo-Betancor O, Moussaud-Lamodiere EL, Soto-Ortolaza AI, Walton RL, Strongosky AJ, Uitti RJ, McCarthy A, Lynch T, Siuda J, Opala G, Rudzinska M, Krygowska-Wajs A, Barcikowska M, Czyzewski K, Puschmann A, Nishioka K, Funayama M, Hattori N, Parisi JE, Petersen RC, Graff-Radford NR, Boeve BF, Springer W, Wszolek ZK, Dickson DW, Ross OA. 2015. Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders. Neurology 85:2016–2025.
16. Seo M, Lee WH, Suk K. 2010. Identification of novel cell migration-promoting genes by a functional genetic screen. FASEB J 24:464–478.
17. Shi CH, Mao CY, Zhang SY, Yang J, Song B, Wu P, Zuo CT, Liu YT, Ji Y, Yang ZH, Wu J, Zhuang ZP, Xu YM. 2016. CHCHD2 gene mutations in familial and sporadic Parkinson's disease. Neurobiol Aging 38:217 e219–217 e213.
18. Shimojima K, Okumura A, Hayashi M, Kondo T, Inoue H, Yamamoto T. 2015. CHCHD2 is down-regulated in neuronal cells differentiated from iPS cells derived from patients with lissencephaly. Genomics 106:196–203.
19. Wei Y, Vellanki RN, Coyaud E, Ignatchenko V, Li L, Krieger JR, Taylor P, Tong J, Pham NA, Liu G, Raught B, Wouters BG, Kislinger T, Tsao MS, Moran MF. 2015. CHCHD2 is coamplified with EGFR in NSCLC and regulates mitochondrial function and cell migration. Mol Cancer Res 13:1119–1129.
20. Wu H, Lu X, Xie F, Cen Z, Zheng X, Luo W. 2016. Genetic analysis of the CHCHD2 gene in a cohort of Chinese patients with Parkinson disease. Neurosci Lett 629:116–118.
21. Yang X, Zhao Q, An R, Zheng J, Tian S, Chen Y, Xu Y. 2016. Mutational scanning of the CHCHD2 gene in Han Chinese patients with Parkinson's disease and meta-analysis of the literature. Parkinsonism Relat Disord 29:42–46.
22. Zhang M, Xi Z, Fang S, Ghani M, Sato C, Moreno D, Liang Y, Lang AE, Rogaeva E. 2016. Mutation analysis of CHCHD2 in Canadian patients with familial Parkinson's disease. Neurobiol Aging 38:e217–e218.